DUBLIN, IRELAND--(Marketwired - Jan 28, 2016) - Horizon Pharma plc (
Canaccord Genuity 2016 Rare Disease, BioPharma 1x1 Day
- Date: February 2, 2016
- Location: New York, NY
BIO CEO & Investor Conference
- Presentation Date: February 8, 2016
- Presentation Time: 2:30 p.m. ET
- Location: New York, NY
LEERINK Partners 5th Annual Global Healthcare Conference
- Date: February 10, 2016
- Presentation Time: 9:15 a.m. ET
- Location: New York, NY
For the above conferences with presentations, they will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com . A replay of the webcasts will be available for the events with presentations.
About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com . Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Investors: John Thomas Executive Vice President, Strategy and Investor Relations Investor-relations@horizonpharma.com Tina Ventura Vice President, Investor Relations investor-relations@horizonpharma.com U.S. Media: Geoff Curtis Senior Vice President, Corporate Communications gcurtis@horizonpharma.com Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie